Several studies have demonstrated that metabolic disorders, such as obesity, insulin resistance, and impaired glucose metabolism, can contribute to the activation of the NLRP3 inflammasome and subsequent neuroinflammation. This evidence concerns the gene NLRP3 and Insulin resistance.